Skip to main content
Clinical Trials/JPRN-jRCTb070190033
JPRN-jRCTb070190033
Recruiting
Phase 1

Reconstruction of vascular access with vascular graft from autologous dermal fibroblasts

Itoh Manabu0 sites3 target enrollmentNovember 7, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
end-stage renal failure
Sponsor
Itoh Manabu
Enrollment
3
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 7, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Itoh Manabu

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \>\=20
  • 2\. Subjects with vascular access for hemodialysis which is judged to need replacement or bypass of stenosis, or replacement of aneurysm
  • 3\. Judged appropriate for this trial from a result of pre\-test
  • 4\. Written informed consent

Exclusion Criteria

  • 1\. Subjects with active infection or medical history
  • 2\. Subjects with positive for syphilis, HBs antigen, HCV antibody, HIV gene, HTLV\-1 antibody, or parvovirus B19 antibody in pre\-test. But, if antibody is positive, judged infectivity
  • 3\. Subject with severe heart failure, or severe liver disorder
  • 4\. Subjects with acute phase myocardial infarction, or cerebral infarction
  • 5\. Subjects with active tumor, or a history of malignant tumor (excluding intraepithelial neoplasia) within 5 years
  • 6\. Subjects with drug dependence, or alcohol dependence
  • 7\. Subjects who participated in other clinical research within 3 months
  • 8\. Subjects who have a history of drug hypersensitivity (including aminoglycosides and polyene antibiotics)
  • 9\. Subjects with allergies to animals (cow) and metals
  • 10\. Subjects with a history of anaphylactic reaction

Outcomes

Primary Outcomes

Not specified

Similar Trials